Multiple Sclerosis Therapeutics Market by Drug Class (Beta Interferon, Corticosteroids, Monoclonal Antibodies, Antineoplastic Agents, and Others), by Route of Administration (Oral and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and Region - Trends, Analysis and Forecast till 2030

The market for treatments for multiple sclerosis is anticipated to be dominated by North America. The market has grown as a result of factors such as a significant increase in public awareness of the various risk factors associated with multiple sclerosis. Furthermore, the United States has a high diagnostic rate, which contributes to a notable increase in prescription rates in this region, allowing it to dominate the market. The multiple sclerosis market in the Asia Pacific region is expected to see significant growth due to the growing involvement of major players who are collaborating with local key players in an effort to capture market share by introducing innovative treatment therapies.